Skip to content

Sunday, July 6, 2025

Latest:

Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

androgen receptor

A microscopic view of prostate cancer. It appears as a field of hazy pink and white with splotches of purple indicating cancer cells.

A novel strategy to suppress prostate cancer growth

October 26, 2022 androgen receptor, castration therapy, COP1, Gata2, Prostate Cancer, Research, treatment resistance

The researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021 Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

The N-terminal domain of the androgen receptor is at the heart of its action

July 30, 2020 androgen receptor, C-terminal domain, coactivators, n-terminal domain, Prostate Cancer, Research, testosterone

Detailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951